Clinical Research Directory

Inclusion Criteria: * Patients with histologically proven metastatic colorectal cancer (stage IV) at time of inclusion (patients with metastatic disease and potential curative treatment intention are allowed) * Age ≥ 18 years * Planned first systemic therapy for metastatic disease * Signed and dated informed consent form * Patients participating in the PRO module: prior to or at start of first systemic treatment for mCRC * Patients not participating in the PRO module: within four weeks after start of fist systemic therapy for mCRC Exclusion Criteria: * Patient who do not receive any systemic therapy for mCRC * Patients whose metastatic disease was surgically resected prior to inclusion and who start adjuvant chemotherapy